Qingquan Zheng

机构：Jiading District Central Hospital, Shanghai University of Medicine and Health Sciences · ORCID：0009-0006-2906-9302

发表论文 10 篇 · 总被引 145 次 · h-index 5

代表论文

• BET proteins: Biological functions and therapeutic interventions (2023 · Pharmacology & Therapeutics · 被引 80)
• Discovery of Novel Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) Inhibitors for Cancer Treatment (2024 · Journal of Medicinal Chemistry · 被引 23)
• Targeting oncogenic transcriptional factor c-myc by oligonucleotide PROTAC for the treatment of hepatocellular carcinoma (2024 · European Journal of Medicinal Chemistry · 被引 19)
• Optimization of 1-Methyl-3-(pyridin-3-yl)-1H-indol Derivatives as ROR1 Inhibitors with Improved Activity and Selectivity (2025 · Journal of Medicinal Chemistry · 被引 8)
• Rational Design, Synthesis, and Biological Evaluation of Novel c-Met Degraders for Lung Cancer Therapy (2025 · Journal of Medicinal Chemistry · 被引 5)
• Lysosome‐targeting chimera (LYTAC): A silver bullet for targeted degradation of oncogenic membrane proteins (2024 · MedComm – Oncology · 被引 5)